Trials / Terminated
TerminatedNCT02049164
Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)
A Randomized, Double-blind, Placebo-controlled, Forced Titration, Dose-ranging Study of AR08 in the Treatment of Vasomotor Symptoms (VMS) in Menopausal Females: A Proof-of-Concept Study
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Arbor Pharmaceuticals, Inc. · Industry
- Sex
- Female
- Age
- 41 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effective dose or dose range of AR08 in the treatment of VMS in menopausal females.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AR08 | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-01-30
- Last updated
- 2015-12-09
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02049164. Inclusion in this directory is not an endorsement.